Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager class drugs
1 result
Kimmtrak (tebentafusp)
(TEBENTAFUSP)Immunocore Commercial LLC
Usage: KIMMTRAK is indicated for HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.